A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

Also called NCT03496207

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03496207
  • EudraCT 2017-004738-27
Other papers using this trial's data
  • Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR) American journal of respiratory and critical care medicine, 2025-06 DOI, PubMed 40035659
  • Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension The European respiratory journal, 2023-01 DOI, PubMed 36041750, PMC9816418 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Brazil, France, Germany, Israel, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03496207. Randomized; quadruple masking; primary purpose treatment. Start 2018-06-13 (actual); primary completion 2022-03-09 (actual). Results posted on 2023-04-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
Acronym
PULSAR
Condition
Pulmonary Arterial Hypertension
Intervention (Drug)
Placebo
Intervention (Drug)
Sotatercept
Intervention (Other)
SOC
Lead sponsor
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA (class: industry)

Record details

Record id
cardio:ct-nct03496207
Content hash
ac34c0b5f4c1a0ab79732dcc5300c17d28a87a06eb2932464160645b6c3391ec